Pharmacy research on a rare genetic disorder may help others seeking to achieve equilibrium
Mike Gibson has been conducting research on a rare neurologic disease for over 30 years. He has recently teamed up with researchers at the University of California San Diego (UCSD) for a two-year project to continue his research on a selected neurological brain disease called succinic semialdehyde dehydrogenase (SSADH) deficiency, a defect of the GABA metabolic pathway.